Unraveling phenotypic variance in metabolic syndrome through multi-omics.

Complex multi-omics effects drive the clustering of cardiometabolic risk factors, underscoring the imperative to comprehend how individual and combined omics shape phenotypic variation. Our study partitions phenotypic variance in metabolic syndrome (MetS), blood glucose (GLU), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), and blood pressure through genome, transcriptome, metabolome, and exposome (i.e.

miRspongeR 2.0: an enhanced R package for exploring miRNA sponge regulation.

Summary: MicroRNA (miRNA) sponges influence the capability of miRNA-mediated gene silencing by competing for shared miRNA response elements and play significant roles in many physiological and pathological processes. It has been proved that computational or dry-lab approaches are useful to guide wet-lab experiments for uncovering miRNA sponge regulation. However, all of the existing tools only allow the analysis of miRNA sponge regulation regarding a group of samples, rather than the miRNA sponge regulation unique to individual samples.

Dynamic cancer drivers: a causal approach for cancer driver discovery based on bio-pathological trajectories.

The traditional way for discovering genes which drive cancer (namely cancer drivers) neglects the dynamic information of cancer development, even though it is well known that cancer progresses dynamically. To enhance cancer driver discovery, we expand cancer driver concept to dynamic cancer driver as a gene driving one or more bio-pathological transitions during cancer progression. Our method refers to the fact that cancer should not be considered as a single process but a compendium of altered biological processes causing the disease to develop over time.

Toward Unique and Unbiased Causal Effect Estimation From Data With Hidden Variables.

Causal effect estimation from observational data is a crucial but challenging task. Currently, only a limited number of data-driven causal effect estimation methods are available. These methods either provide only a bound estimation of causal effects of treatment on the outcome or generate a unique estimation of the causal effect but making strong assumptions on data and having low efficiency.

Exploring cell-specific miRNA regulation with single-cell miRNA-mRNA co-sequencing data.

Background: Existing computational methods for studying miRNA regulation are mostly based on bulk miRNA and mRNA expression data. However, bulk data only allows the analysis of miRNA regulation regarding a group of cells, rather than the miRNA regulation unique to individual cells. Recent advance in single-cell miRNA-mRNA co-sequencing technology has opened a way for investigating miRNA regulation at single-cell level.

PAN: Personalized Annotation-Based Networks for the Prediction of Breast Cancer Relapse.

The classification of clinical samples based on gene expression data is an important part of precision medicine. In this manuscript, we show how transforming gene expression data into a set of personalized (sample-specific) networks can allow us to harness existing graph-based methods to improve classifier performance. Existing approaches to personalized gene networks have the limitation that they depend on other samples in the data and must get re-computed whenever a new sample is introduced.

Computational methods for cancer driver discovery: A survey.

Identifying the genes responsible for driving cancer is of critical importance for directing treatment. Accordingly, multiple computational tools have been developed to facilitate this task. Due to the different methods employed by these tools, different data considered by the tools, and the rapidly evolving nature of the field, the selection of an appropriate tool for cancer driver discovery is not straightforward.

miRSM: an R package to infer and analyse miRNA sponge modules in heterogeneous data.

In molecular biology, microRNA (miRNA) sponges are RNA transcripts which compete with other RNA transcripts for binding with miRNAs. Research has shown that miRNA sponges have a fundamental impact on tissue development and disease progression. Generally, to achieve a specific biological function, miRNA sponges tend to form modules or communities in a biological system.

GraphDTA: predicting drug-target binding affinity with graph neural networks.

Summary: The development of new drugs is costly, time consuming and often accompanied with safety issues. Drug repurposing can avoid the expensive and lengthy process of drug development by finding new uses for already approved drugs. In order to repurpose drugs effectively, it is useful to know which proteins are targeted by which drugs.

A pseudotemporal causality approach to identifying miRNA-mRNA interactions during biological processes.

Motivation: microRNAs (miRNAs) are important gene regulators and they are involved in many biological processes, including cancer progression. Therefore, correctly identifying miRNA-mRNA interactions is a crucial task. To this end, a huge number of computational methods has been developed, but they mainly use the data at one snapshot and ignore the dynamics of a biological process.

LMSM: A modular approach for identifying lncRNA related miRNA sponge modules in breast cancer.

Until now, existing methods for identifying lncRNA related miRNA sponge modules mainly rely on lncRNA related miRNA sponge interaction networks, which may not provide a full picture of miRNA sponging activities in biological conditions. Hence there is a strong need of new computational methods to identify lncRNA related miRNA sponge modules. In this work, we propose a framework, LMSM, to identify LncRNA related MiRNA Sponge Modules from heterogeneous data.

Correction to: Identifying miRNA synergism using multiple-intervention causal inference.

After publication of this supplement article [1], it was brought to our attention that the Fig. 3 was incorrect. The correct Fig.

Identifying miRNA synergism using multiple-intervention causal inference.

Background: Studying multiple microRNAs (miRNAs) synergism in gene regulation could help to understand the regulatory mechanisms of complicated human diseases caused by miRNAs. Several existing methods have been presented to infer miRNA synergism. Most of the current methods assume that miRNAs with shared targets at the sequence level are working synergistically.

miRspongeR: an R/Bioconductor package for the identification and analysis of miRNA sponge interaction networks and modules.

Background: A microRNA (miRNA) sponge is an RNA molecule with multiple tandem miRNA response elements that can sequester miRNAs from their target mRNAs. Despite growing appreciation of the importance of miRNA sponges, our knowledge of their complex functions remains limited. Moreover, there is still a lack of miRNA sponge research tools that help researchers to quickly compare their proposed methods with other methods, apply existing methods to new datasets, or select appropriate methods for assisting in subsequent experimental design.

Multi-Source Causal Feature Selection.

Causal feature selection has attracted much attention in recent years, as the causal features selected imply the causal mechanism related to the class attribute, leading to more reliable prediction models built using them. Currently there is a need of developing multi-source feature selection methods, since in many applications data for studying the same problem has been collected from various sources, such as multiple gene expression datasets obtained from different experiments for studying the causes of the same disease. However, the state-of-the-art causal feature selection methods generally tackle a single dataset, and a direct application of the methods to multiple datasets will result in unreliable results as the datasets may have different distributions.

miRBaseConverter: an R/Bioconductor package for converting and retrieving miRNA name, accession, sequence and family information in different versions of miRBase.

Background: miRBase is the primary repository for published miRNA sequence and annotation data, and serves as the "go-to" place for miRNA research. However, the definition and annotation of miRNAs have been changed significantly across different versions of miRBase. The changes cause inconsistency in miRNA related data between different databases and articles published at different times.

Estimating heterogeneous treatment effect by balancing heterogeneity and fitness.

Background: Estimating heterogeneous treatment effect is a fundamental problem in biological and medical applications. Recently, several recursive partitioning methods have been proposed to identify the subgroups that respond differently towards a treatment, and they rely on a fitness criterion to minimize the error between the estimated treatment effects and the unobservable ground truths.

Results: In this paper, we propose that a heterogeneity criterion, which maximizes the differences of treatment effects among the subgroups, also needs to be considered.

LncmiRSRN: identification and analysis of long non-coding RNA related miRNA sponge regulatory network in human cancer.

Motivation: MicroRNAs (miRNAs) are small non-coding RNAs with the length of ∼22 nucleotides. miRNAs are involved in many biological processes including cancers. Recent studies show that long non-coding RNAs (lncRNAs) are emerging as miRNA sponges, playing important roles in cancer physiology and development.

Inferring and analyzing module-specific lncRNA-mRNA causal regulatory networks in human cancer.

It is known that noncoding RNAs (ncRNAs) cover ∼98% of the transcriptome, but do not encode proteins. Among ncRNAs, long noncoding RNAs (lncRNAs) are a large and diverse class of RNA molecules, and are thought to be a gold mine of potential oncogenes, anti-oncogenes and new biomarkers. Although only a minority of lncRNAs is functionally characterized, it is clear that they are important regulators to modulate gene expression and involve in many biological functions.

CancerSubtypes: an R/Bioconductor package for molecular cancer subtype identification, validation and visualization.

Summary: Identifying molecular cancer subtypes from multi-omics data is an important step in the personalized medicine. We introduce CancerSubtypes, an R package for identifying cancer subtypes using multi-omics data, including gene expression, miRNA expression and DNA methylation data. CancerSubtypes integrates four main computational methods which are highly cited for cancer subtype identification and provides a standardized framework for data pre-processing, feature selection, and result follow-up analyses, including results computing, biology validation and visualization.